Edgewood Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Hold |
35,000
| – | – | ﹤0.01% | 60 |
|
|
2025
Q1 | $1.03M | Buy |
35,000
+5,000
| +17% | +$147K | ﹤0.01% | 66 |
|
|
2024
Q4 | $986K | Hold |
30,000
| – | – | ﹤0.01% | 66 |
|
|
2024
Q3 | $1.33M | Hold |
30,000
| – | – | ﹤0.01% | 59 |
|
|
2024
Q2 | $1.29M | Hold |
30,000
| – | – | ﹤0.01% | 60 |
|
|
2024
Q1 | $877K | Hold |
30,000
| – | – | ﹤0.01% | 61 |
|
|
2023
Q4 | $668K | Hold |
30,000
| – | – | ﹤0.01% | 62 |
|
|
2023
Q3 | $743K | Hold |
30,000
| – | – | ﹤0.01% | 61 |
|
|
2023
Q2 | $850K | Hold |
30,000
| – | – | ﹤0.01% | 58 |
|
|
2023
Q1 | $689K | Hold |
30,000
| – | – | ﹤0.01% | 60 |
|
|
2022
Q4 | $842K | Hold |
30,000
| – | – | ﹤0.01% | 56 |
|
|
2022
Q3 | $848K | Buy |
+30,000
| New | +$848K | ﹤0.01% | 53 |
|
|
2022
Q2 | – | Sell |
-20,000
| Closed | -$582K | – | 78 |
|
|
2022
Q1 | $582K | Buy |
+20,000
| New | +$582K | ﹤0.01% | 67 |
|